Goethe-Universität Frankfurt am Main

Fenfluramine in clinical practice: new therapy option for Dravet and Lennox–Gastaut syndromes (2024) Muhle H, Kurlemann G, Lehmann I, Hamer H, Mayer T, Potschka H, Schubert-Bast S, et al. Journal article Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study. (2024) Kaeley GS, Schett G, Conaghan PG, McGonagle D, Behrens F, Goupille P, Gaillez C, et al. Journal article Out-of-sample predictability of firm-specific stock price crashes: A machine learning approach (2024) Kaya D, Reichmann D, Reichmann M Journal article Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients (2024) Rios CA, Qayed M, Etra AM, Reshef R, Newcomb R, Yuhasz N, Hexner EO, et al. Journal article Pathological tissue changes in brain tumors affect the pH-sensitivity of the T1-corrected apparent exchange dependent relaxation (AREX) of the amide protons (2024) Steidl E, Neuhaus E, Shrestha M, Deichmann R, Weber K, Steinbach JP, Pilatus U, et al. Journal article Fast and Long-Term Super-Resolution Imaging of Endoplasmic Reticulum Nano-structural Dynamics in Living Cells Using a Neural Network (2024) Rahm JV, Balakrishnan A, Wehrheim M, Kaminer A, Glogger M, Kessler LF, Kaschube M, et al. Journal article Was braucht es, um forschungsfit zu sein? Fokusgruppendiskussionen mit Hausärzt*innen und Medizinischen Fachangestellten (2024) Wolf F, Klanke M, Klein AA, Kuschick D, Lingner H, Löscher S, Stark S, Mergenthal K Journal article Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adults. (2024) Feuchtinger T, Bader P, Subklewe M, Breidenbach M, Willier S, Metzler M, Gökbuget N, et al. Journal article, Review article Ferroptosis in health and disease. (2024) Berndt C, Alborzinia H, Amen VS, Ayton S, Barayeu U, Bartelt A, Bayir H, et al. Journal article, Review article Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party (2024) Duque-Afonso J, Finke J, Ngoya M, Galimard JE, Schetelig J, Eder M, Rösler W, et al. Journal article